Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

ICICI Prudential Life Insurance - Growing share of non ICICI bank channels a long term positive - ICICI Securities

Posted On: 2021-01-27 22:46:37 (Time Zone: Arizona, USA)


The big strategic takeaway from 9MFY21 result of ICICI Prudential Life Insurance (IPRU) is the evolving silhouette of an ex-ICICI Bank product as well as distribution strategy. Key effects of this strategy include: (1) Growth in non-linked savings portfolio by healthy 35% in 9MFY21 YoY, (2) introduction of guaranteed savings as well as limited deferred annuity products, which is a shift from the erstwhile stance justified by the availability of suitable external hedging products (FRAs and 30-year G-Sec bonds) and (3) spurt in new distribution channels with 83 new partnerships including prominent banks. As such, despite ICICI Bank's contribution declining to 34% of the overall APE in 9MFY21, total APE/VNB is down ~27%/9.3% YoY in 9MFY21. However, such a strategic rejig can continue to have a near term volume as well as margin impact. Post 22% run up in price since 28th Oct'20, we downgrade the stock from Buy to ADD.

- Retail protection growth has moderated in-line with industry trend in Q3FY21. Total protection in Q3/9MFY21 declined 4%/8% YoY with moderation in retail protection, in-line with the industry trends. However, IPRU had been aggressive in taking price hikes post the increase in reinsurance rates which could also have had an effect on the retail protection volumes in Q2/Q3FY21. Total Protection APE has gradually flattened from Rs2.14bn in Q1FY21 to Rs2.32bn in Q2FY21 to Rs2.57bn in Q3FY21. Credit protect has evolved from a decline in Q1FY21 to moderate growth in Q3FY21, while group term has surprised positively in Q3FY21.

- ULIP revival steadily visible. ULIP business had steadily improved over the year with Q1/Q2/Q3 APE at Rs3.6/7.0/8.45bn, respectively. Recovery in ULIPs, as also seen with other insurers, remains a possible volume trigger in CY22.

- Persistency shows sequential improvement, 61st month bucket notably better. Compared to 11MFY21, retail persistency (excluding the single premium) remains lower in all but 61st month cohort. However, 13th / 61st month persistency was for higher for 8MFY21 cohort compared to 2MFY21. Total Covid claims (net of reinsurance) was Rs1.54bn. IPRU has an additional provision of Rs1bn towards Covid-19 which has not been utilised so far.

- Non-ULIP non-protection APE growth remains robust. This segment has increased by 43% in 9MFY21 underlying the efforts of the company to diversify the portfolio. The company has done tie ups with IDFC First Bank, IndusInd Bank, NSDL Payments Bank, RBL Bank and AU SFB in 9MFY21.

- Doubling VNB over FY19-FY23 to Rs26bn is a stiff target; downgrade from Buy to ADD. Based on 27% YoY decline in 9MFY21 APE, we have assumed 23% YoY decline in FY21. With an improving ULIP share, FY21 VNB/VNB margin is likely to be Rs13.4bn/24.5%. We ascribe 20x multiple to FY23E VNB of Rs20bn to arrive at a target price of Rs530 (implied FY22E P/EV of 2.2).

Shares of ICICI Prudential Life Insurance Company Ltd was last trading in BSE at Rs.499.35 as compared to the previous close of Rs. 502. The total number of shares traded during the day was 111774 in over 7029 trades.

The stock hit an intraday high of Rs. 506.55 and intraday low of 497.5. The net turnover during the day was Rs. 55973940.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Initiating Coverage - Mastek Ltd - HDFC Securities Retail Research Desk

Hindalco Industries - Status quo maintained - ICICI Securities

Tata Motors - India business scaling in the right direction - ICICI Securities

IPO Review - Heranba Industries Ltd



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020